These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20205282)

  • 21. Screening for familial colorectal cancer with a sensitive immunochemical fecal occult blood test: a pilot study.
    Gimeno-García AZ; Quintero E; Nicolás-Pérez D; Hernández-Guerra M; Parra-Blanco A; Jiménez-Sosa A
    Eur J Gastroenterol Hepatol; 2009 Sep; 21(9):1062-7. PubMed ID: 19307978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. FECAL OCCULT BLOOD: A COMPARISON OF CHEMICAL AND IMMUNOCHEMICAL TESTS.
    Borges LV; Mattar R; Silva JMKD; Silva ALWD; Carrilho FJ; Hashimoto CL
    Arq Gastroenterol; 2018; 55(2):128-132. PubMed ID: 30043860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accuracy of advanced endoscopy and fecal calprotectin for prediction of relapse in ulcerative colitis: a prospective study.
    Jauregui-Amezaga A; López-Cerón M; Aceituno M; Jimeno M; Rodríguez de Miguel C; Pinó-Donnay S; Zabalza M; Sans M; Ricart E; Ordás I; González-Suárez B; Cuatrecasas M; Llach J; Panés J; Pellise M
    Inflamm Bowel Dis; 2014 Jul; 20(7):1187-93. PubMed ID: 24874457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
    Pillet S; Jarlot C; Courault M; Del Tedesco E; Chardon R; Saint-Sardos P; Presles E; Phelip JM; Berthelot P; Pozzetto B; Roblin X
    Inflamm Bowel Dis; 2015 Jul; 21(7):1580-6. PubMed ID: 25933392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two-year delay in ulcerative colitis diagnosis is associated with anti-tumor necrosis factor alpha use.
    Kang HS; Koo JS; Lee KM; Kim DB; Lee JM; Kim YJ; Yoon H; Jang HJ
    World J Gastroenterol; 2019 Feb; 25(8):989-1001. PubMed ID: 30833804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of a desk top instrument for the automated development and immunochemical quantification of fecal occult blood.
    Rozen P; Waked A; Vilkin A; Levi Z; Niv Y
    Med Sci Monit; 2006 Jun; 12(6):MT27-32. PubMed ID: 16733493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The severity of inflammation at onset of ulcerative colitis is not associated with IBS-like symptoms during clinical remission.
    Jonefjäll B; Simrén M; Öhman L; Lasson A; Svedlund J; Strid H
    J Crohns Colitis; 2015 Sep; 9(9):776-83. PubMed ID: 26079726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison between a guaiac and three immunochemical faecal occult blood tests in screening for colorectal cancer.
    Faivre J; Dancourt V; Denis B; Dorval E; Piette C; Perrin P; Bidan JM; Jard C; Jung S; Levillain R; Viguier J; Bretagne JF
    Eur J Cancer; 2012 Nov; 48(16):2969-76. PubMed ID: 22572481
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a Combined Human Transferrin-Hemoglobin Lateral Immunochromatographic Assay for Accurate and Rapid Fecal Occult Blood Test.
    Ye Y; Deng Y; Mao J; Yan Q; Huang Y; Zhang J; Zheng J; Li Y; Chen W
    Clin Lab; 2018 May; 64(5):805-813. PubMed ID: 29739056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fecal occult blood testing when colonoscopy capacity is limited.
    Wilschut JA; Habbema JD; van Leerdam ME; Hol L; Lansdorp-Vogelaar I; Kuipers EJ; van Ballegooijen M
    J Natl Cancer Inst; 2011 Dec; 103(23):1741-51. PubMed ID: 22076285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient reported symptoms during an ulcerative colitis flare: a Qualitative Focus Group Study.
    Waljee AK; Joyce JC; Wren PA; Khan TM; Higgins PD
    Eur J Gastroenterol Hepatol; 2009 May; 21(5):558-64. PubMed ID: 19194304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical utilization of digital rectal examination and fecal occult blood testing upon hospital admission.
    Scales CD; Fein S; Muir AJ; Rockey DC
    J Clin Gastroenterol; 2006; 40(10):913-8. PubMed ID: 17063111
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse.
    Gisbert JP; Bermejo F; Pérez-Calle JL; Taxonera C; Vera I; McNicholl AG; Algaba A; López P; López-Palacios N; Calvo M; González-Lama Y; Carneros JA; Velasco M; Maté J
    Inflamm Bowel Dis; 2009 Aug; 15(8):1190-8. PubMed ID: 19291780
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fecal occult blood test as a tool for improved outpatient qualification for colonoscopy. A single-center experience and 10-year follow-up survey.
    Banaszkiewicz Z; Budzyński J; Tojek K; Jarmocik P; Frasz J; Mrozowski M; Świtoński M; Jawień A
    Adv Med Sci; 2017 Mar; 62(1):171-176. PubMed ID: 28282604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study.
    Bernerth K; Schiefke I; Liebscher K; Raczynski S; Kottmann T; Teich N
    BMC Res Notes; 2018 Dec; 11(1):853. PubMed ID: 30514356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Early detection of bowel cancer in occupational surveillance examinations: switching from a guaiak-based to an immunochemical fecal occult blood test].
    Webendörfer S; Riemann JF
    Dtsch Med Wochenschr; 2014 Jan; 139(3):79-83. PubMed ID: 24089288
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average risk population.
    Guittet L; Bouvier V; Mariotte N; Vallee JP; Arsène D; Boutreux S; Tichet J; Launoy G
    Gut; 2007 Feb; 56(2):210-4. PubMed ID: 16891354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of four fecal assays in the diagnosis of colitis.
    Schoepfer AM; Trummler M; Seeholzer P; Criblez DH; Seibold F
    Dis Colon Rectum; 2007 Oct; 50(10):1697-706. PubMed ID: 17762964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being.
    Jonefjäll B; Öhman L; Simrén M; Strid H
    Inflamm Bowel Dis; 2016 Nov; 22(11):2630-2640. PubMed ID: 27636379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predicting Ulcerative Colitis Relapse in Clinical Remission With Fecal Immunochemical Occult Blood Test or Prostaglandin E-Major Urinary Metabolite.
    Ishida N; Matsuura T; Asai Y; Miyazu T; Tamura S; Tani S; Yamade M; Iwaizumi M; Hamaya Y; Osawa S; Furuta T; Sugimoto K
    Clin Transl Gastroenterol; 2022 Jul; 13(7):e00501. PubMed ID: 35616320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.